Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 611,100 shares, a decline of 28.4% from the October 15th total of 853,200 shares. Based on an average trading volume of 11,550,000 shares, the days-to-cover ratio is presently 0.1 days.
Analyst Ratings Changes
Separately, StockNews.com raised shares of Applied DNA Sciences to a “sell” rating in a research report on Tuesday, September 17th.
Get Our Latest Report on Applied DNA Sciences
Applied DNA Sciences Stock Performance
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Recommended Stories
- Five stocks we like better than Applied DNA Sciences
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Rocket Lab is the Right Stock for the Right Time
- How to Use the MarketBeat Stock Screener
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How is Compound Interest Calculated?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.